Congenital Hematological Disorder Completed Phase Trials for Benzalkonium (DB11105)
Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder
| Indication | Status | Phase |
|---|---|---|
| DBCOND0081791 (Congenital Hematological Disorder) | Completed | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01586936 | Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors | ||
| NCT01579968 | Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery | ||
| NCT01579955 | Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice |